Education hub

SolpaOne 1000 mg Effervescent Tablets (P) contain paracetamol. For short term symptomatic treatment of mild to moderate pain and/or fever. Adults and children over 16 years and weighing over 50 kg: 1 tablet dissolved in water every 6 hours as needed. Max 4 tablets in 24 hours. Do not use in children under 16 years and weighing less than 50 kg. Do not take with other paracetamol-containing products. In case of overdose, seek immediate medical advice, even if the patient feels well. Contraindications: known hypersensitivity to the ingredients. Caution: renal or hepatic impairment, chronic alcoholism, non-cirrhotic alcoholic liver disease, Gilbert’s syndrome, haemolytic anaemia, dehydration or chronic malnutrition, glucose-6-phosphate dehydrogenase deficiency, paracetamol can interfere with laboratory tests. Product contains sodium (1 tablet equivalent to 26.68% recommended daily intake) and sorbitol. Interactions: probenecid, cholestyramine, rifampicin, carbamazepine, phenytoin, phenobarbital, primidone, warfarin and other coumarins, salicylamide, metoclopramide, domperidone, isoniazid, flucloxacillin, St John’s wort, and chloramphenicol. Side effects: hypersensitivity reaction, angioedema, anaphylactic shock, aspirin-sensitive bronchospasm, platelet disorders, stem cell disorders, thrombocytopenia, leukopenia, haemolytic anaemia, pancytopenia, methaemoglobinaemia, agranulocytosis, hepatic failure, hepatic necrosis, hepatitis, severe renal impairment, gastrointestinal haemorrhage, hypoglycaemia, Interstitial nephritis and serious skin reactions. PL 36390/0411. MAH: Cipla (EU) Limited Dixcart House, Addlestone Road, Bourne Business Park, Addlestone, Surrey, KT15 2LE, UK. Date of preparation: 06/2023. RRP (ex. VAT): 12s £5.19.
SPC: https://mhraproducts4853.blob.core.windows.net/docs/9baaa3ca1885c55ae41f5f7817565ee3186d26b7

Buttercup Bronchostop Cough Syrup (GSL) contains thyme herb extract and marshmallow root extract. A traditional herbal medicinal pr oduct for the relief of coughs, such as chesty coughs and dry, tickly, irritating coughs and catarrh, exclusively based upon long-standing use as a traditional remedy. Adults and children over 12 years: 15ml every 4 hours, 4 times per day. Max 6 doses (90ml) per day. Max dose should not be exceeded. To be taken 30 to 60 minutes before or after intake of other medicines. Not recommended for children under 12 years. To be administrated undiluted or diluted in water or warm tea. Seek medical advice if symptoms persist after 7 days or if dyspnoea, fever or purulent sputum occurs. Contraindications: Hypersensitivity to marshmallow root, thyme, to other members of the Lamiaceae family or to any of the excipients. Warnings and precautions: Asthmatics and atopic patients should consult a doctor before using the medicine. Contains E218 and E216 that may cause allergic reactions (possibly delayed). Patients with HFI, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take the medicine. The additive effect of concomitantly administered products containing fructose (or sorbitol) and dietary intake of fructose (or sorbitol) should be considered. Pregnancy and lactation: Not recommended. Side effects: pruritus, rash, urticaria, angioedema, anaphylactic reaction, oral mucosal blistering, abdominal pain, diarrhoea, nausea, vomiting, dyspnoea, exacerbation of asthma. THR 02855/0336. THR Holder: Omega Pharma Ltd, 32 Vauxhall Bridge Rd, London SW1V 2SA. Revision date: 06/2021. RRP (ex.VAT) 120ml £6.99 / 200ml £9.99 / 240ml £10.99. SPC: https://mhraproducts4853.blob.core.windows.net/docs/5cb628e93b7d644c7523e4e22d8c54a4fdfd6be8

Buttercup Bronchostop Cough Pastilles (GSL) contain thyme herb extract. A traditional herbal medicinal pr oduct for the relief of coughs, such as chesty coughs and dry, tickly, irritating coughs and catarrh, exclusively based upon long-standing use as a traditional remedy. Adults and children over 12 years: 1 – 2 pastilles every 4 hours. Max dose 12 pastilles per day. Not recommended for children under 12 years. Seek medical advice if symptoms persist after 7 days or if dyspnoea, fever or purulent sputum occurs. Contraindications: Hypersensitivity thyme, or to any of the excipients. Warnings and precautions: Asthmatics and atopic patients should consult a doctor before using the medicine. Contains E1519 that may cause allergic reactions. Patients with HFI should not take the medicine. The additive effect of concomitantly administered products containing fructose (or sorbitol) and dietary intake of fructose (or sorbitol) should be considered. Pregnancy and lactation: Not recommended. Side effects: pruritus, rash, urticaria, angioedema, anaphylactic reaction, oral mucosal blistering, abdominal pain, diarrhoea, nausea, vomiting, dyspnoea, exacerbation of asthma. THR 02855/0337. THR Holder: Omega Pharma Ltd, 32 Vauxhall Bridge Rd, London SW1V 2SA. Revision date: 06/2021. RRP (ex.VAT) 10s £3.99 / 20s £5.99 / 40s £9.99. SPC: https://mhraproducts4853.blob.core.windows.net/docs/9021b7d42a0c1f518d4839e2703d67b417024a54

Beconase^® Hayfever/Beconase^® Allergy (P) contains beclometasone dipropionate. For the prevention and treatment of allergic rhinitis, including hay fever,in adults over 18 years. Adults aged 18 and over: 2 sprays into each nostril morning and evening (400 micrograms/day). Not recommended for use in children and adolescents under 18 years. Contraindications: Known hypersensitivity to ingredients. Caution: Recent nasal injury or surgery, pregnancy/lactation. Side effects: Rare cases of hypersensitivity reactions, dryness/irritation of the nose and throat, raised intra-ocular pressure, nasal septal perforation. PL 02855/0064. MAH: Omega Pharma Ltd, Wrafton, Braunton, Devon, EX33 2DL. RRP (ex VAT): £10.99 Date of preparation: November 2022. SPC: https://mhraproducts4853.blob.core.windows.net/docs/add7cb6160f716a8078810c7cf2e590df15e99df

Beconase^® Hayfever Relief for Adults 0.05% Nasal Spray (GSL) contains beclometasone dipropionate. For the treatment of seasonal allergic rhinitis (hay fever) in adults over 18 years. Adults aged 18 and over: 2 sprays into each nostril morning and evening (400 micrograms/day). Not recommended for use in children and adolescents under 18 years. Contraindications: Known hypersensitivity to ingredients. Caution: Concomitant use of other corticosteroid treatments, recent nasal injury or surgery, pregnancy/lactation. Side effects: Rare cases of hypersensitivity reactions, dryness/irritation of the nose and throat, raised intra-ocular pressure, nasal septal perforation. PL 02855/0065. MAH: Omega Pharma Ltd, Wrafton, Braunton, Devon, EX33 2DL. RRP (ex. VAT): £7.99. Date of preparation: November 2022. SPC: https://mhraproducts4853.blob.core.windows.net/docs/9ba7c8e045c6acf535cdf1e11eb58da4be19be10 BecoDefence^®/BecoDefence Kids^®/ BecoDefence Plus^® are medical devices. Contraindications: Known hypersensitivity to ingredients or those with a Sesame oil allergy in BecoDefence^® and BecoDefence Kids^®. Known hypersensitivity to ingredients or those with a Sesame oil/perilla seed oil allergy in BecoDefence Plus^®.